Glaxo, Eon Settle Wellbutrin Patent Dispute
Eon's Bupropion drug is the generic equivalent of GlaxoSmithKline's Wellbutrin (bupropion HCl extended- release).
Under terms of the settlement, GlaxoSmithKline has agreed to drop any further effort to pursue its claim that Bupropion HCl, ER 100 mg and 150 mg tablets infringe its patents.
On Nov. 26, the Food and Drug Administration approved Eon’s tablet...
To view the full article, register now.